IGC Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.

About IGC

IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. 

CEO
Ram Mukunda
CEORam Mukunda
Employees
70
Employees70
Headquarters
Potomac, Maryland
HeadquartersPotomac, Maryland
Founded
2005
Founded2005
Employees
70
Employees70

IGC Key Statistics

Market cap
37.16M
Market cap37.16M
Price-Earnings ratio
-5.15
Price-Earnings ratio-5.15
Dividend yield
Dividend yield
Average volume
800.45K
Average volume800.45K
High today
$0.46
High today$0.46
Low today
$0.4002
Low today$0.4002
Open price
$0.4162
Open price$0.4162
Volume
789.37K
Volume789.37K
52 Week high
$0.4985
52 Week high$0.4985
52 Week low
$0.2525
52 Week low$0.2525

IGC News

TipRanks 3d
IGC Pharma expands Phase 2 CALMA trial to University of South Florida

IGC Pharma (IGC) announced the expansion of its ongoing Phase 2 CALMA clinical trial evaluating investigational drug candidate IGC-AD1 for agitation in Alzheime...

People also own

Based on the portfolios of people who own IGC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.